DSIJ Mindshare

India's largest listed pharmaceutical company, Sun Pharma spiked by more than 5 per cent in early trade on Monday, on the back of a market buzz that the company's Halol facility will be inspected by the USFDA. At 10:58 hours, the stock of Sun Pharma was quoting 597.30 per share, up 3.21 per cent.

Overall volumes in futures & options currently stand at 42.37 lakh contracts with a turnover of Rs. 3,66,338.98 crore.

Overall volumes in futures & options currently stand at 42.37 lakh contracts with a turnover of Rs. 3,66,338.98 crore.

As long as Nifty holds the low of Friday, i.e. 10,520, the bias would be positive and buying on dips would be an ideal strategy for the traders. On the upside, targets likely for the day would be 10,600, followed by 10,640. In case the Friday’s low of 10,520,is breached, Nifty is likely to extended its correction up to the level of 10,480.  

Indian shares are expected to extend the jubilant mood with a positive start on the back of bullish global cues. The SGX Nifty suggests that the Nifty could open above 10,600 landmark with gains of 41 points at the opening bell.